Nuclear accumulation of glioma-associated oncogene 2 protein and enhanced expression of forkhead-box transcription factor M1 protein in human hepatocellular carcinoma

Histology and Histopathology

Volumn 25, Issue 10, 2010, Pages 1269-1275

  Lin, M ^a   Guo, L M ^a   Liu, H ^b   Du, J ^a   Yang, J ^a   Zhang, L J ^b   Zhang, B ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Forkhead box transcription factor M1; Glioma associated oncogene 2; Hedgehog pathway; Hepatocellular carcinoma; Immunohistochemistry

Indexed keywords

ERINACEIDAE;

FORKHEAD TRANSCRIPTION FACTOR; FOXM1 PROTEIN, HUMAN; GLI2 PROTEIN, HUMAN; KRUPPEL LIKE FACTOR; NUCLEAR PROTEIN;

ADULT; AGED; ARTICLE; CANCER STAGING; CELL DIFFERENTIATION; CELL NUCLEUS; CELL PROLIFERATION; CHEMISTRY; CHI SQUARE DISTRIBUTION; CHINA; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; LIVER TUMOR; MALE; MIDDLE AGED; PATHOLOGY; PROGNOSIS; UPREGULATION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CELL DIFFERENTIATION; CELL NUCLEUS; CELL PROLIFERATION; CHI-SQUARE DISTRIBUTION; CHINA; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNOHISTOCHEMISTRY; KRUPPEL-LIKE TRANSCRIPTION FACTORS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; NUCLEAR PROTEINS; PROGNOSIS; UP-REGULATION;

EID: 79952031233     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Berman D.M., Karhadkar S.S., Maitra A., de Oca R.M., Gerstenblith M.R., Briggs K., Parker A.R., Shimada Y., Eshleman J.R., Watkins D.N. and Beachy P.A. (2003). Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours. Nature 425, 846-851.
2. Calvisi D.F., Pinna F., Ladu S., Pellegrino R., Simile M.M., Frau M., De Miglio M.R., Tomasi M.L., Sanna V., Muroni M.R., Feo F. and Pascale R.M. (2009). Forkhead box M1B is a determinant of rat susceptibility to hepatocarcinogenesis and sustains ERK activity in human HCC. Gut 58, 679-687.
3. Chan D.W., Yu S.Y.M., Chui P.M., Yao K.M., Liu V.W.S., Cheung A.N.Y. and Ngan H.Y.S. (2008). Over-expression of FOXM1 transcription factor is associated with cervical cancer progression and pathogenesis. J. Pathol. 215, 245-252.
4. Clement V., Sanchez P., de Tribolet N., Radovanovic I. and Altaba A. (2007). Hedgehog-GLI1 signaling regulates human glioma growth, cancer stem cell self-renewal, and tumorigenicity. Curr. Biol. 17, 165-172.
5. Dahmane N., Lee J., Robins P., Heller P. and Altaba A. (1997). Activation of the transcription factor GLI1 and the sonic hedgehog signaling pathway in skin tumors. Nature 389, 876-881.
6. Douard, R., Moutereau S., Pernet P., Chimingqi M., Allory Y., Manivet P., Conti M., Vaubourdolle M., Cugnenc P.H. and Loric S. (2006). Sonic hedgehog-dependent proliferation in a series of patients with colorectal cancer. Surgery 139, 665-670.
7. El-Serag H.B. and Rudolph K.L. (2007). Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterol. 132, 2557-2576.
8. Huang S., He J., Zhang X., Bian Y., Yang L., Xie G., Zhang K., Tang W., Stelter A.A., Wang Q., Zhang H. and Xie J. (2006). Activation of the hedgehog pathway in human hepatocellular carcinomas. Carcinogenesis 27, 1334-1340.
9. Ikram M.S., Neill G.W., Regl G. and Eichberger T. (2004). GLI2 is expressed in normal human epidermis and BCC and induces GLI1 expression by binding to its promoter. J. Invest. Dermatol. 122, 1503-1509.
10. Jeong J., Mao J., Tenzen T., Kottmann A.H. and McMahon A.P. (2004). Hedgehog signaling in the neural crest cells regulates the patterning and growth of facial primordia. Genes Dev. 18, 937-951.
11. Jiang J. and Hui C.C. (2008). Hedgehog signaling in development and cancer. Dev. Cell 15, 801-812.
12. Jung Y., McCall S.J., Li Y.X. and Diehl A.M. (2007). Bile ductules and stromal cells express hedgehog ligands and/or hedgehog target genes in primary biliary cirrhosis. Hepatology 45, 1091-1096.
13. Karhadkar S.S., Bova G.S., Abdallah N., Dhara S., Gardner D., Maitra A., John T., Isaacs J.T., Berman D.M. and Beachy P.A. (2004). Hedgehog signaling in prostate regeneration, neoplasia and metastasis. Nature 431, 707-712.
14. Kasper M., Regl G., Frischauf A.M. and Aberger F. (2006). Gli transcription factors: mediators of oncogenic hedgehog signaling. Eur. J. Cancer 42, 437-445.
15. Katoh M. and Katoh M. (2004). Human FOX gene family. Int. J. Oncol. 25, 1495-1500.
16. Katoh Y. and Katoh M. (2005). Hedgehog signaling pathway and gastric cancer. Cancer Biol. Ther. 4, 1050-1054.
17. Kim I.M., Ackerson T., Ramakrishna S., Tretiakova M., Wang I.C., Kalin T.V., Major M.L., Gusarova G.A., Yoder H.M., Costa R.H. and Kalinichenko V.V. (2006). The Forkhead box m1 transcription factor stimulates the proliferation of tumor cells during development of lung cancer. Cancer Res. 66, 2153-2161.
18. Kim J.E., Singh R.R., Cho-Vega J.H., Drakos E., Davuluri Y., Khokhar F.A., Fayad L., Medeiros L.J. and Vega F. (2009). Sonic hedgehog signaling proteins and ATP-binding cassette G2 are aberrantly expressed in diffuse large B-cell lymphoma. Mod. Pathol. 22, 1312-1320.
19. Kim Y.S., Yoon J.W., Xiao X.K., Dean N.M., Monia B.P. and Marcusson E.G. (2007). Selective down-regulation of glioma-associated oncogene 2 inhibits the proliferation of hepatocellular carcinoma cells. Cancer Res. 67, 3583-3593.
20. Lehmann O.J., Sowden J.C., Carlsson P., Jordan T. and Bhattacharya S.S. (2003). Fox's in development and disease. Trends Genet. 19, 339-344.
21. Liao X., Siu M.K.Y., Au C.W.H., Wong E.S.Y., Chan H.Y., Ip P.P.C., Ngan H.Y.S. and Cheung A.N.Y. (2009). Aberrant activation of hedgehog signaling pathway in ovarian cancers: effect on prognosis, cell invasion and differentiation. Carcinogenesis 30, 131-140.
22. Lipinski R.J., Gipp J.J., Zhang J., Doles J.D. and Bushman W. (2006). Unique and complimentary activities of the Gli transcription factors in Hedgehog signaling. Exp. Cell Res. 312, 1925-1938.
23. Maeda Y., Davé V. and Whitsett J.A. (2007). Transcriptional control of lung morphogenesis. Physiol. Rev. 87, 219-244.
24. Narita S., Ettinger S., Hayashi N., Muramaki M., Fazli L., Kim Y. and Gleave M.E. (2008). GLI2 knockdown using an antisense oligonucleotide induces apoptosis and chemosensitizes cells to paclitaxel in androgen-independent prostate cancer. Clin. Cancer Res. 14, 5769-5777.
25. Ohta H., Aoyagi K., Fukaya M., Danjoh I., Ohta A., Isohata N., Saeki N., Taniguchi H., Sakamoto H., Shimoda T., Tani T., Yoshida T. and Sasaki H. (2009). Cross talk between hedgehog and epithelialmesenchymal transition pathways in gastric pit cells and in diffusetype gastric cancers. Br. J. Cancer 100, 389-398.
26. Pasca di Magliano M. and Hebrok M. (2003). Hedgehog signaling in cancer formation and maintenance. Nat. Rev. Cancer 3, 903-911.
27. Patil M.A., Zhang J., Ho C., Cheung S.T., Fan S.T. and Chen X. (2006). Hedgehog signaling in human hepatocellular carcinoma. Cancer Biol. Ther. 5, 111-117.
28. Regl G., Kasper M., Schnidar H., Eichberger T., Neill G.W., Ikram M.S., Quinn A.G., Philpott M.P., Frischauf A.M. and Aberger F. (2004). The zinc-finger transcription factor GLI2 antagonizes contact inhibition and differentiation of human epidermal cells. Oncogene 23, 1263-1274.
29. Scales S.J. and de Sauvage F.J. (2009). Mechanisms of hedgehog pathway activation in cancer and implications for therapy. Trends Pharmacol. Sci. 30, 303-312.
30. Sicklick J.K., Li Y.X., Choi S.S., Qi Y., Chen W., Bustamante M., Huang J., Zdanowicz M., Camp T., Torbenson M.S., Rojkind M. and Diehl A.M. (2005). Role for hedgehog signaling in hepatic stellate cell activation and viability. Lab Invest. 85, 1368-1380.
31. Sicklick J.K., Li Y.X., Jayaraman A., Kannangai R., Qi Y., Vivekanandan P., Ludlow J.W., Owzar K., Chen W., Torbenson M.S. and Diehl A.M. (2006). Dysregulation of the hedgehog pathway in human hepatocarcinogenesis. Carcinogenesis 27, 748-757.
32. Sims-Mourtada J., Izzo J.G., Apisarnthanarax S., Wu T.T., Malhotra U., Luthra R., Liao Z., Komaki R., van der Kogel A., Ajani J. and Chao K.S. (2006). Hedgehog: an attribute to tumor regrowth after chemoradio therapy and a target to improve radiation response. Clin. Cancer Res. 12, 6565-6572.
33. Teh M.T., Wong S.T., Neill G.W., Ghali L.R., Phipott M.P. and Quinn A.G. (2002). FOXM1 is a downstream target of Gli1 in basal cell carcinoma. Cancer Res. 62, 4773-4780.
34. Thayer S.P., di Magliano M.P., Heiser P.W., Nielsen C.M., Roberts D.J., Lauwers G.Y., Qi Y.P., Gysin S., Fernández-del Castillo C., Yajnik V., Antoniu B., McMahon M., Warshaw A.L. and Hebrok M. (2003). Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis. Nature 425, 851-856.
35. Thiyagarajan S., Bhatia N., Reagan-Shaw S., Cozma D., Thomas-Tikhonenko A., Ahmad N. and Spiegelman V.S. (2007). Role of GLI2 transcription factor in growth and tumorigenicity of prostate cells. Cancer Res. 67, 10642-10646.
36. Varjosalo M. and Taipale J. (2008). Hedgehog: functions and mechanisms. Genes Dev. 22, 2454-2472.
37. Wang X.H., Kiyokawa H., Dennewitz M.B. and Costa R.H. (2002). The Forkhead Box m1b transcription factor is essential for hepatocyte DNA replication and mitosis during mouse liver regeneration. Proc. Natl. Acad. Sci. USA 99, 16881-16886.
38. Wang Z.W., Banerjee S., Kong D., Li Y. and Sarkar F.H. (2007). Downregulation of forkhead box M1 transcription factor leads to the inhibition of invasion and angiogenesis of pancreatic cancer cells. Cancer Res. 67, 8293-8300.
39. Watkins D.N., Berman D.M., Burkholder S.G., Wang B., Beachy P.A. and Baylin S.B. (2003). Hedgehog signalling within airway epithelial progenitors and in small-cell lung cancer. Nature 422, 313-317.
40. Yoon J.W., Kita Y., Frank D.J., Majewski R.R., Konicek B.A., Nobrega M.A., Jacob H., Walterhouse D. and Iannaccone P. (2002). Gene expression profiling leads to identification of Gli1-binding elements in target genes and a role for multiple downstream pathways in Gli1-induced cell transformation. J. Biol. Chem. 277, 5548-5555.